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RADIOTERAPI SELEPAS MASTEKTOMI YANG MELIBATKAN NOD 
SUPRAKLAVIKAL - DOS GARIS TINDIHAN, DOS TUMOR DAN DOS 
ORGAN BERISIKO 
 
ABSTRAK 
 
Tujuan kajian ini ialah untuk menyelidiki kesan pertindihan akibat daripada 
pencapahan alur medan tangen terhadap medan supraklavikal dalam penyinaran payu 
dara pesakit yang menerima rawatan radioterapi payu dara, meneliti dos terserap 
dalam kulit pesakit untuk rawatan tersebut dan menentukan dos dalam payu dara 
kontralateral (CB) dalam fantom yang difabrikasi dan juga dalam pesakit bagi teknik 
2-medan dan teknik 3-medan yang digunakan dalam penyinaran dinding dada 
selepas mastektomi. 
Fantom heterogen torso wanita dewasa bersaiz sederhana yang difabrikasi, 
satu set dosmeter termoluminesen (TLD), filem terapi megavoltan, dan diod 
VeriDose jenis-n telah digunakan untuk pengukuran dos. Empat teknik yang berbeza 
telah digunakan dalam kajian ini; teknik pertindihan, teknik katil berputar yang 
digunakan secara rutin di Pusat Kanser Mount Miriam, Pulau Pinang, teknik jurang 5 
mm menggunakan rahang tak simetri untuk menghalang medan supraklavikal yang 
digunakan secara rutin di Hospital Pantai Mutiara, Pulau Pinang dan teknik jurang 5 
mm menggunakan medan bersimetri. Semua rawatan telah dilaksanakan 
menggunakan terapi sinaran 3-dimensi berbentuk menggunakan alur foton 6 MV. 
Sistem perancang rawatan (TPS) (Plato RPS V2.6.3, Nucleotron) menggunakan 
algoritma alur pensel untuk penghitungan dos. Penghitungan dos TPS telah 
dinormalkan terhadap isopusat medan tangen dan terhadap dmaks untuk medan 
supraklavikal. 
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Tiga satah sagital daripada medan supraklavikal hingga ke medan tangen dan 
satu satah melintang sepanjang garis sepadan bagi ketiga-tiga medan dipilih untuk 
membandingkan dos yang dihitung dan yang diukur dalam rantau sepadan. 
Pengukuran dos dilaksanakan terhadap 34 pesakit yang menerima rawatan 
radioterapi alur luar di Pusat Kanser Mount Miriam dalam tempoh masa antara Jun 
2008 dan September 2008. 
Min penghasilan semula bacaan TLD dan filem berkisar pada 3 % bagi satu 
sisihan piawai. Dos daripada filem dan TLD telah dibandingkan dengan dos yang 
dihitung daripada TPS. Dos yang diukur dan dihitung di rantau sepadan yang dipilih 
adalah sama di sekitar 11 % untuk filem dan di sekitar 12 % untuk TLD. Apabila 
kesepadanan, jurang dan pertindihan dicapai untuk pengukuran yang teliti dalam 
fantom, ketakpastian total untuk diod bagi kedua-dua penentukuran dos masuk dan 
dos keluar adalah dalam lingkungan 5 % untuk keadaan rujukan dan bukan rujukan. 
Secara penghampirannya dos keluar dan dos masuk yang diukur dan dihitung untuk 
pesakit mempunyai perhubungan linear di antara satu sama lain untuk. Nisbah purata 
dos CB yang diukur terhadap dos CB yang dihitung menggunakan algoritma alur 
pensel adalah lebih kurang 53 % sementara pada dmaks, nisbahnya adalah < 11 %. 
Min dan median dos CB dalaman yang diukur pada kedalaman berbeza dalam 
fantom pada permukaan adalah 5.47 ± 0.22 cGy dan 5.44 cGy masing-masing. 
 
xxv 
 
POST-MASTECTOMY RADIOTHERAPY INVOLVING SUPRACLAVICAL 
NODES – MATCHLINE DOSE, TUMOUR DOSE AND ORGANS AT RISK 
DOSE 
 
ABSTRACT 
 
 The purposes of this study were investigated the effect of the overlap 
resulting from the beam divergence of the tangential fields onto a supraclavicular 
field in breast irradiation of patients undergoing breast radiotherapy, to examine the 
absorbed dose to the skin of patients in such treatments and to determine the dose in 
contralateral breast (CB) from 2-field and 3-field techniques used in post-
mastectomy chest wall irradiations in a fabricated phantom as well as in patients.  
 A heterogeneous fabricated phantom of an adult medium female torso, a set 
of thermoluminescent dosimeters (TLDs), megavoltage therapy films, and an n-type 
VeriDose diode were used in the dose measurements. Four different techniques were 
used in this study, overlap technique, couch rotating technique which is routinely 
applied in Mount Miriam Cancer Centre, Penang, a gap of 5 mm technique using 
asymmetric jaws to block the supraclavicular field which is routinely applied in 
Pantai Mutiara Hospital, Penang, and a 5 mm gap technique using symmetrical field. 
All treatments have been done with three-dimensional conformal radiation therapy 
(3D-CRT) using 6 MV photon beams. The treatment planning system (TPS) (Plato 
RPS V2.6.3, Nucleotron) uses the pencil beam algorithm for dose calculations. The 
TPS dose calculations were normalized at the isocentre of the tangential fields and at 
dmax for the supraclavicular field.  
 Three sagittal planes from the supraclavicular field down to the tangential 
fields and one transversal plane along the match line of the three fields were selected 
to compare the measured and calculated dose in the match region. Dose 
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measurements were performed on thirty-four patients undergoing external beam 
radiotherapy at the Mount Miriam Cancer Centre, during the period between June 
2008 and September 2008 
 The mean reproducibility of TLD and film readings was within 3% for one 
standard deviation. Doses from films and TLDs were compared to the calculated 
doses from the TPS. In the matching selected regions, the measured and calculated 
doses agreed within 11 % for films and 12 % for TLDs. In phantom, where care was 
taken to achieve the necessary match, gap and overlap, the total uncertainty for the 
diode from both the entrance and the exit dose calibration was within 5 % for 
reference and non-reference conditions. The measurements and calculations doses 
for the patients are approximately linearly related to each other for entrance and exit 
dose. The average ratio of the measured to the calculated CB dose using the pencil 
beam algorithm was approximately 53% while at dmax the ratio was < 11%. The mean 
and median measured internal CB dose at different depths in a phantom at surface 
was 5.47 ± 0.22 cGy and 5.44 cGy respectively. 
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CHAPTER 1 
INTRODUCTION 
 
 
1.1 Role of Breast Radiotherapy 
Radiotherapy is given for primary carcinoma of the breast to reduce 
recurrence. Researchers have found that radiotherapy is beneficial for patients 
particularly for improving survival after mastectomy. The removal of lymph glands 
containing cancer cells results in the need for radiotherapy for the remaining areas to 
reduce the risk of recurrence. For example, after mastectomy, radiotherapy may be 
given to the chest wall if the tumour is more than 5 cm in diameter (Dobbes et al., 
1999). 
Often radiotherapy may be used before, or instead of, surgery. For inoperable 
T3 and T4 tumours, various strategies are involved such as the inclusion of 
chemotherapy or hormone therapy. Operable tumours 3 – 4 cm or more in diameter 
is candidate for recurrence if radiotherapy is used in conjunction with conservative 
surgery, and therefore chemotherapy is more preferred (Dobbes et al., 1999). 
In Malaysia breast cancer is the dominant type of female cancer and is 
affecting one in 19 women and over 4000 new cases is reported annually 
(http://www. makna.org.my/breastcancer.asp, 2008). In the United States the 
projected breast cancer incidence was 178,480 in 2007 (Jemal et al., 2007). Total 
mastectomy is normally performed for approximately 60-70 % of the reported cases 
in Malaysia followed by radiotherapy. According to the American Society for 
Therapeutic Radiology and Oncology (ASTRO) guidelines, post-mastectomy 
radiation therapy (PMRT) is recommended for patients with tumours > 5 cm and / or 
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with > 4 positive axillary lymph nodes. PMRT is also considered when patients have 
negative nodes but have adverse multiple features such as primary tumour > 2 cm, 
unsatisfactory surgical margins and lymphovascular invasion (Bese et al., 2006).  
The increase in survival manifests in a study of mastectomy. On the lighter 
side, more positive cosmetic appearance of the breasts of some patients after 
radiotherapy was observed. This highlights the role of radiotherapy. For conservative 
surgery, some study indicates that it actually decreases the incidence of Ductal 
Carcinoma in Situ (DCIS) recurrence and development of invasive diseases. 
The presence of high grade malignancy tumour if incompletely excised or if 
there is tumour close to the excision margin constitutes a high risk factor and calls 
for the application of radiotherapy to the chest wall. In other cases however, 
irradiation is unnecessary such as when an axillary dissection up to the lower border 
of the pectoralis minor is not done. However if axillary nodes are involved, radiation 
may be given to the axilla and supraclavicular fossa. 
Tumours in the central and medial quadrant require irradiation to the internal 
mammary nodes. Past experiences have shown that local recurrences are rare in these 
circumstances and therefore routine radiotherapy is not recommended. Other related 
method of control for recurrence such as in the case of critical breast conservation is 
the adoption of interstitial implantation. This will give a boost to the site of excision 
following lumpectomy and external beam radiation as part of the treatment. 
 
1.2 Breast Anatomy 
The breast is made up of the mammary gland, fat, blood vessels, nerves, and 
lymphatics as shown in Fig. 1.1.  (Kopans, 1987; Haagensen, 1971)  The surface of 
the breast has deep attachments of fibrous septa, called Cooper's ligament, which 
runs between the superficial fascia (attached to the skin) and the deep fascia 
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(covering the pectoralis major and other muscles of the chest wall). (Del Regato et 
al.,1977). 
The mammary gland lies over the pectoralis major muscle and extends from 
the second to the sixth rib in the vertical plane and from the sternum to the anterior or 
even midaxillary line.  (Del Regato et al., 1977)  An additional layer of mammary 
tissue extends laterally into the axilla to a variable degree. This axillary projection, 
often called the tail, is sometimes quite prominent and should always be kept in mind 
during examinations and in planning radiation therapy. 
The retro mammary bursa lies between the deep layer of the superficial fascia 
and the deep fascia; it contains loose areolar tissue that allows for mobility over the 
chest wall. (Haagensen, 1971) It is crossed by projections of the deep layer of the 
superficial fascia that joins with the deep pectoral fascia to form the posterior 
suspensory ligaments of the breast. Deep projections of mammary parenchyma may 
extend between the muscle bundles of the pectoralis major muscle. The mammary 
consists of glandular tissue arranged in multiple lobes composed of lobules 
connected in ducts, areolar tissue, and blood vessels. The smallest  lobules  consist of  
clusters of  rounded alveoli  that open  into the small branches of the lactiferous ducts 
(Fig. 1.2);  these unite and form larger ducts  that eventually converge into single 
canals in the nipple, corresponding to each lobe of the gland  (15 to 20 galactophori). 
(Kopans, 1989). 
A network of lymphatics is formed over the entire surface of the chest, neck, 
and abdomen and becomes dense under the areola. Mammary gland lymphatics 
begin in the interlobular or prelobular spaces, follow the ducts, and end in the 
subareolar network of lymphatics of the skin. (Del Regato et al., 1977; Haagensen, 
1971)  The following lymphatic  pathways originate mostly in the base of the breast:  
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(1) the axillary or principal pathway passes from the upper and lower halves of the 
breast to the lateral chain of nodes situated between the second and  third intercostal  
space; (2) the transpectoral pathway passes through the pectoralis major muscle to 
the supraclavicular lymph nodes; and (3) the internal mammary pathway passes 
through the midline, through the pectoralis major and  intercostal muscles, usually  
close to the sternum, to the nodes of the internal mammary chain. The main 
lymphatic channels of the breast are illustrated in Fig. 1.3. 
 
 
 
Figure 1.1:  Anatomy of the breast and lymphatic drainage. Anatomy of axilla (pectoralis 
major and minor muscles partially removed to demonstrate anatomic levels of lymph nodes). 
Internal mammary artery and vein (1), substernal cross drainage to contralateral internal 
mammary lymphatic chain (2); subclavian muscle and Halsted’s ligament (3); lateral 
pectoral nerve (from lateral cord) (4); pectoral branch from thoracoacromial vein (5); 
pectoralis minor muscle (6); pectoralis major muscle (7); lateral thoracic vein (8); medial 
pectoral nerve (from medial cord) (9); pectoralis minor muscle (10); median nerve (11); 
subcapsular vein (12); thoracodorsal vein (13); internal mammary lymph nodes (A); apical 
lymph nodes (B); interpectoral (Rotter’s) lymph nodes (C); axillary vein lymph nodes (D); 
central lymph nodes (E); scapular lymph nodes (F); external mammary lymph nodes (G). 
Level I lymph nodes lateral to lateral border of pectoralis minor muscle; level II lymph nodes 
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behind pectoralis minor muscle; level III lymph nodes medial to medial border of pectoralis 
minor muscle. (Osborne, 1987) 
 
 
Figure 1.2: Microscopic structure of the mammary gland. Ducts extend back from the 
nipple independent of one another, each defining a lobe of the breast.  The major ducts 
arborize, culminating in the terminal lobular units. The ducts are lined by an epithelial layer 
in which ductal cancer is thought to arise. Most cancer is thought to arise in the   extralobular   
terminal duct. (Kopans, 1989) 
 
Figure 1.3: Anatomy of the lymphatic routes of the breast.  (Dobbes et al., 1999). 
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1.3 Treatment Field Arrangements 
The patient lies supine on the simulator couch with a suitable immobilization, 
the position of the patient aligned using laser lights. The field’s borders are marked 
on the skin with the centre points of medial and lateral fields. Three reference tattoo 
points are made at medial, lateral field centres, and at the opposite side of the body. 
 
1.3.1 Breast and Chest Wall 
The most common set-up for breast cancer patients is a two field x-ray 
approach with the patient supine, ipsilateral arm above head (Murshed, 2006) as 
shown in Fig. 1.4. The first field is the medial tangent field and the second is the 
lateral tangent field. The medial tangent field border starts at the patient midline, it 
involves the linac gantry to be positioned over the patient and slightly off to one side 
so the beam can enter the breast at a tangential angle. Figure 1.5 shows the lateral 
field with gantry positioned off to the ipsilateral side and slightly below the table 
level. Figure 1.6 shows transversal plane of the fields for two beam open field 
therapy. 
 
 
Figure 1.4: Anterior view of the patient set-up with medial tangential field. A Bright 
yellow: breast being treated, B Light yellow: beam in air, not touching woman, C Opening 
of the linear accelerator, D Arm holder supports woman's right arm (Taken from http://www. 
breastcancer.org/treatment/radiation/types/ext/) 
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Figure 1.5: Lateral view of the patient set-up with Lateral tangential field. A Bright 
yellow: breast being treated, B Light yellow: beam in air, not touching woman, C Opening 
of the linear accelerator, D Arm holder (Taken from http://www.breastcancer.org/treatment   
/ radiation/types/ext/) 
 
 
 
 
 
Figure 1.6: Cross-sectional view of patient receiving radiation to the breast area. A Middle 
radiation beam, B Side radiation beam, C Bright yellow: place where radiation is given to the 
breast, D Rib cage/chest wall, E Heart, F Lungs, G Backbone, H Sternum / breastbone. 
(Taken from http://www.breastcancer.org/treatment/radiation/types/ext/) 
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1.3.2 Chest Wall and Lymph Nodes 
The two tangential fields are used for treating the breast or chest wall.  A single 
anterior field can be used to irradiate the supraclavicular nodes only as shown in Fig. 
1.7. The superior border extends at least 3 cm above the medial end of the clavicle. 
Medial border is placed 1 cm apart to the patient midline to avoid the larynx and 
spinal cord. Lateral border lies at the junction of the medial two-thirds and the lateral 
one-third of the clavicle. The inferior border is at the lower border of the clavicle 
(Dobbes et al., 1999). 
 
 
Figure 1.7: Anterior view for three-field technique. (Dobbes et al., 1999). 
 
1.3.3 Matching the Tangential Fields with the Supraclavicular Field (SCF) 
An overdose caused by divergence of the tangential beams into the 
supraclavicular field and of the supraclavicular beam into the tangential fields can 
exist just beneath the skin surface at the junction of the inferior border of the 
Supraclavicular Field 
Medial 
Tangential Fields 
Lateral 
Tangential Fields 
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supraclavicular field and the superior border of the tangential fields. (Bedwinek, 
1981) The sharp beam of a linear accelerator and the "horns" at the edge of this beam 
produce a marked increase in dose beneath the matchline if these divergences are not 
corrected. This increased dose may result in severe matchline fibrosis or even rib 
fracture. 
 
1.3.4 Matching the Tangential Fields with the Internal Mammary Field 
 When an internal mammary field is required, the match between it and the 
medial tangential field can be a problem if there is a significant amount of breast 
tissue beneath the matchline. In this situation, underdose areas can exist (Figure 
1.8A). The effect may be negligible if the breast tissue beneath this matchline is thin 
(Figure 1.8B), or it can be avoided by not using a separate internal mammary field 
(Figure 1.8C). In the latter case, the internal mammary nodes must be included in the 
tangential beams (as determined by CT scan or radionuclide scintigraphy). Usually 
this can be achieved by moving the medial tangential field border 3 to 5 cm across 
the midline. The portal films should be inspected carefully to ensure that an 
excessive amount of lung or heart is not being irradiated. There is no good solution 
to this matchline problem in large-chested women who also have a significant 
amount of breast tissue beneath the matchline of the tangential and internal 
mammary fields. Woudstra and van der Werf, (1987) described a technique using an 
oblique incidence of the internal mammary portal to match the orientation of the 
adjacent medial tangential portal; this results in a more homogeneous dose 
distribution at the junction of the two fields.  
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Figure 1.8: Diagrams showing several relationships between internal mammary and 
tangential fields. (A) A significant cold region exists if the internal mammary (IM) tangential 
matchline overlies a large amount of breast tissue.  (B) The cold area may be negligible if the 
breast tissue beneath the matchline is thin. (C)  The lack of a  separate IM field  can result  in  
irradiation  of an  excessive  volume of  lung, particularly  in  large-chested patients.  
(Bedwinek, 1981) 
 
 
1.4 Research Objectives 
 
The principal objectives of this research can be summarized in the following 
points 
1) To examine different types of high-energy dosimeters such as TLD, films, 
and Si diode during breast cancer radiotherapy. 
2) To compare different dosimetric techniques for investigating underdose and 
overdose in radiotherapy treatment planning. 
3) To compare breast irradiation techniques in terms of reproducibility and 
accuracy. 
4) To investigate the entrance and exit doses in vivo in breast radiotherapy with 
a 6 MV photon beam. 
5) To investigate the dose for contralateral breast during radiotherapy treatment. 
The local radiotherapy departments in Malaysia current situation is that they are 
using some breast irradiation techniques without research done for dose 
measurement for the matchline dose, tumour dose, and organ at risk (Contralateral 
Breast).  
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1.5 Structure of this Thesis 
 
This thesis contains seven chapters having the common theme, dose 
measurements in problematic treatment fields in breast cancer radiotherapy. Chapter 
1 provides background information on external breast radiation therapy, spread of 
lymphatic routes of breast anatomy, description of treatment fields, and the main 
objectives of this research. 
A literature review on the dose measurements in problematic breast cancer 
radiotherapy and organs at risk is given in chapter 2. It is divided into four broad 
categories: i) Matchline of supraclavicular and tangential breast fields techniques, ii) 
Lung and heart dose during breast radiotherapy, iii) Entrance and exit dose, and iv) 
Contralateral breast dose. Chapter 3 describes the instrumentation utilized in this 
research. There were two main categories of instruments used, namely the detectors 
and the TLD reader with the ancillary equipments. The detectors employed included 
the TLDs which are described in greater detail whereas other detector types such as 
n-type Si semiconductor diodes and the film dosimeters are also touched upon. The 
central piece of material for the research is the phantom. Three types of phantoms 
were described, namely the solid water phantom, perspex phantom and the 
heterogeneous phantom. The perspex plays a major role in this research. As a treatise 
in instrumentation, the simulator and linear accelerator (LINAC) are also described. 
Validation of the experimental work for dose calculations and measurements 
is provided in the following four chapters. Chapter 4 presents the three field 
technique in post-mastectomy chest wall radiotherapy involving supraclavicular 
nodes. Four different techniques (overlap, couch rotating, 5 mm gap asymmetric jaw, 
and 5 mm gap symmetrical field) were examined and experiments carried out to 
compare the calculation results with the measurements. The dosimeters’ response 
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behaviors were studied. For LiF:Mg;Ti TLD, the characterization included seven 
parameters with respect to reproducibility, linearity, field size, angular dependence, 
effect of wedge, dose rate dependence and percentage depth dose. In the case of film, 
only the calibration curve and the percentage depth dose curve were studied. 
In chapter 5 the entrance and exit dose for lateral, medial (tangential fields) 
and three fields were investigated. 6 MV photon beam for breast radiotherapy now 
employed was used with TLDs and also the n-type VeriDose Diode for patient 
dosimetry. The latter is further elaborated on dose perturbation, calibration for the 
entrance and exit doses and temperature dependence. An observation on the 
parameters affecting measurements was also presented. 
Chapter 6 presents a comparative study of the contralateral breast in phantom 
and patient dosimetry. Finally, chapter 7 concludes the thesis providing a summary 
of the major results and potential avenues for future work. 
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CHAPTER 2 
LITERATURE REVIEW 
 
 
2.1 Matchline of Supraclavicular and Tangential Breast Fields Techniques 
The treatment of the breast and adjacent lymph nodes requires a complicated 
irradiation technique due to the irregular target volume that lies close to the critical 
organs. Frequently, a technique that utilizes three fields is used. Typically this 
consists of the application of two opposite tangential fields for breast, chest wall, and 
ipsilateral internal mammary lymph nodes irradiation. A third anterior field is 
applied to irradiate supraclavicular and axilla lymph nodes. Overdosage as a result of 
an overlap of the supraclavicular, axillary and tangential breast fields can cause 
unacceptable fibrosis and cosmetic impairment (Harris et al., 1979; Clarke et al., 
1983; and Pezner et al., 1985). An underdosage area as a result of a gap can 
contribute to tumour recurrence. It is therefore important that tangential breast fields 
and supraclavicular fields are matched as precisely as possible. A further 
complication of the tangential field treatment is the location of internal mammary 
nodes over an oblique plane close to the sternum. While irradiating the internal 
mammary nodes a low dose should be maintained to underlying lung tissue. Several 
ways have been proposed to solve these problems (Svensson et al., 1980; Siddon et 
al., 1980; Siddon et al., 1983; Podgorsak et al., 1984; Lebesque, 1986; and Litcher et 
al., 1986). To avoid the overlap from beam divergence and to carefully match the 
adjacent fields, Podgorsak et al., (1984) suggested the use of half beam blocks. Many 
techniques have been proposed to achieve uniform dose distributions across the 
junction of abutting tangential and supraclavicular fields. Most of these approaches 
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attempt to avoid over- or underdosage through a combination of couch rotation, 
collimator rotation, half beam blocks, asymmetric jaws or beam splitters.  
 Svensson et al., (1980) were the first to describe an isocentric technique 
which produced a geometric alignment between the supraclavicular field (SCF) and 
tangential breast fields using a hanging corner block on the superior border of the 
tangential fields and modified the beam divergence by rotating the couch. Mounted 
corner was replaced of hanging block by (Siddon et al., 1983). 
Hunt et al. (1987) compared the dose distributions for different treatment 
techniques. These authors analyzed the influence of various geometrical parameters 
on the dose distribution in the match region. In all these techniques, however, no 
gaps or overlaps are assumed between adjacent fields. In a previous study Holmberg 
et al., (1994) determined in vivo the accuracy of field matching in breast cancer 
irradiation using an electronic portal imaging device assessed the four field edge 
positions in the cranial match plane of tangential breast fields and supraclavicular-
axillary fields. The mean gap/overlap of the four fields for individual patients during 
each treatment session was +0.5 mm indicating that no systematic gap or overlap was 
observed. The uncertainty in the position of the tangential and supraclavicular fields 
with respect to the match plane ranged from 3.1 to 5.1 mm (1 SD) for the individual 
patients. Therefore, it can be expected that these set-up uncertainties will cause dose 
fluctuations across the abutment of matching fields. The effect of set-up uncertainties 
on the dose across the junction of matching craniospinal fields in the treatment of 
medulloblastoma has been investigated by Holupka et al., (1993). Only limited 
information is available, however, for such a dose perturbation during breast 
treatment (Marshall, 1993). Therefore, Idzes et al. (1998) evaluated the dose 
distribution in the match region when an optimal match is achieved and in cases 
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when gaps and overlaps occur between adjacent fields as a result of set-up 
uncertainties. 
The divergence of the tangential fields into the SCF and vice versa can cause 
over dosage which may result in severe matchline fibrosis or even rib fracture (Perez 
and Brady, 1997). On the other hand, under dosage can result from a gap in between 
tangential fields and the SCF (Idzes et al., 1998) and it could increase the recurrence 
rate.   
 
2.2 Lung and Heart Dose during breast Radiotherapy 
Breast cancer radiotherapy patients usually receive radiotherapy to the breast 
and chest wall as part of their treatment because parts of the anterior lung will be 
included in the tangential radiation fields. The aim of the treatment is to deliver a 
uniform dose to the target volume (breast with or without the regional nodes) while 
sparing as much as possible the adjacent normal tissue. While such irradiation does 
not cause a clinically relevant problem, it is sometimes accompanied with clinically 
significant pneumonitis, particularly in patients previously treated with 
chemotherapy (Lingos et al., 1991; Mah et al., 1994).    
The treatment techniques practiced in most departments have undergone 
evolution in line with the advances in technology. Dose comparison studies of 
modern techniques with those practiced in the earlier studies indicate a reduction in 
cardiac and lung dose and volume, predicting a decreased risk of cardiac and lung 
morbidity as a result (Price et al., 1990; Host et al., 1986; Fuller et al., 1992). A 
variety of methods have been proposed to aid in the reduction of the volume of lung 
and heart encompassed in the target volume. These include modified electron/photon 
field arrangements (Hurkmans et al., 2000), patients suspending their breathing 
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during treatment (Lu et al.; 2000), the practice of setting a maximum acceptable lung 
volume (Dobbs, 2000), and the ipsilateral arm raised in an optimum position forcing 
the breast anteriorly away from the lung (Canney et al.; 1999).  
The primary indicator suggested as a guide to the lung volume included 
within the treatment volume is the central lung distance (CLD) (Lirette et al., 1995 
and Das et al., 1998). This is the distance between the posterior field edge and the 
anterior edge of the lung at the field central axis plane. Alternative indicators of the 
lung/heart volume can be derived from portal images of the tangential fields or from 
CT scans of the target volume acquired using either a simulator CT (Mallik et al., 
1995) or a CT simulator. 
Dose-volume analysis for three-dimensional (3D) CT patient data were 
studied by evaluation of the tangential treatment technique (Fuller et al., 1992; 
Gagliardi et al., 1996; Gyenes et al., 1997; Gagliardi et al., 1998; Das et al., 1998; 
and Nixon et al., 1998). In modern techniques including the locoregional lymph 
nodes in the target volume a few detailed information is available about cardiac 
doses (Pakisch et al., 1991 and Jansson et al., 1998). 
Pakisch et al. (1991) calculated dose-volume histograms of the lungs and 
heart for treatment techniques including the lymph nodes in the target volume. 
However, they did not outline the target volume, so no information about target 
coverage was available. Jansson et al. (1998) presented data about heart and lung 
doses and target coverage, but the new technique which they studied can only be 
employed on an Medium Mammary 22 or Medium Mammary 50 Racetrack 
microtron of which only a few exist in the world. They compared their new 
technique with a tangential irradiation technique, which has the disadvantage that 
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generally a considerable part of the contralateral breast has to be included to obtain 
adequate target coverage. 
A correlation between CLD and irradiated lung volume has been studied by 
Bornstein et al., (1990) and Carter et al., (1997).  Bornstein et al., (1990) described a 
technique in which the collimator is rotated parallel to the chest wall such that the 
deep field edge is defined by the collimator. In the technique utilized by Carter et al., 
(1997) study technique, the collimator is not rotated and the deep field edge is 
defined by a block, which is generally designed to follow the contour of the chest 
wall. In the technique used by Bornstein et al., (1990), the thickness of the lung 
shadow near the cephalad and caudal field edges are likely to be less than at the lung 
shadow at the central axis, owing to the curvature of the chest. Bornstein et al., 
(1990) reported a mean of 90% prediction interval to involve ±7% of ipsilateral lung 
volume. On the other hand, Carter et al., (1997) reported a ±5% variability of 
ipsilateral lung volume. Van Tienhoven et al., (1991) have studied the impact of 
variabilities on irradiated lung. He reported that respiratory movement has minimal 
influence on treatment volume. Similarly, Carter et al., (1997) suggested that typical 
variations in treatment setup have a small impact on irradiated lung volume. 
It has been shown in previous studies that breathing suitability techniques can 
be used to reduce the radiation to heart and lung volumes, originally by exploiting 
lung inflation to reduce the amount of lung tissue in the radiation fields and spatially 
separate the heart from the target. Recently, Pedersen et al., (2004) and Korreman et 
al., (2005)  have shown in two CT-studies that both voluntary deep inspiration 
breath-hold and free breathing end-inspiration gating can provide lung and heart dose 
reductions. Corresponding relative cardio-pulmonary normal tissue complication 
probability (NTCP) reductions were reported to be of the order of 85% for 
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pneumonitis and 95% for cardiac mortality (Korreman et al., 2006a). Both the 
dosimetric and complication probability effects were slightly larger with the deep 
inspiration breath-hold technique than with the inspiration gating technique, however 
these differences were not statistically significant. 
Since January 2004, the free breathing end-inspiration gating technique 
implemented with the Real-Time Position Management (RPM)TM system has been in 
routine clinical use at Copenhagen University Hospital institution. Audio coaching is 
used for all patients to increase the inspiration level of breathing, and is 
individualized in a training session prior to the planning CT-scanning. A study by 
Korreman et al., (2006b) was the first that reported dose distributions and predicted 
normal tissue toxicities for a population of patients treated with the free breathing 
inspiration gating technique for breast cancer. 
 
2.3 Entrance and Exit Dose for Breast Treatment 
 Human skin consists of three main layers: they are in alternation epidermis, 
basal layer and dermis. The epidermis is mostly composed of dead cells and their 
function is mainly for protection. The thickness of the epidermis varies at different 
sites of the human body: approximately 4–5 mg/cm2 thick on head, neck, trunk and 
upper parts of limbs, 10-15 mg/cm2 at the back of hands and feet, and 30–40 mg/cm2 
on the palm and soles (Keirim-Markus, 1991). The basal layer, located at the lowest 
part of epidermis, is the skin cell provider and is considered to be where the skin 
damage occurs while receiving a radiation dose (Hopewell, 1991; ICRP, 1991; 
ICRU, 1985). 
Both the oncologist and medical physicist are interested to know the dose at 
this specified region as well as the dose beyond. These are important pieces of 
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information for avoiding unwanted skin complication and for the treatment of the 
lymphatic system at the depth of 0.5 mm (Kron et al., 1993). However, the dose 
measurement of the basal layer is rather difficult and complicated owing to the fact 
that the thickness and composition of skin vary at different parts of the human body 
and at some sites the basal layer is even waves and overlapped with capillary 
glomerules. Nevertheless, the basal layer in thinner skin, as in a human body, is 
flatter and nearly constantly thick; this makes the use of an ultra-thin dosimeter 
possible in vivo. 
Measurements of skin dose and exit dose have been studied by various 
methods (Purdy, 1986; Rikner and Grussel, 1989; Thomas and Palmer, 1989; 
Rawlinson et al., 1992; Kron et al., 1993). Many types of detectors can be used for in 
vivo dosimetry (ICRU, 1976; Mckinlay, 1981; Rikner and Grussel, 1987); 
nevertheless, TLD and semiconductors are the most commonly used. A comparison 
of both detectors is worth being done in clinical practice of conventional treatments 
because the physical properties involved in the detection process are different and the 
calibration methodology requires some correction factors that are specific to each 
type of detector (Auket, 1991). Based on these arguments, we intended to measure 
entrance and exit doses with both dosemeters for breast patients treated isocentrically 
with external photon beam therapy. This feasibility study is aimed at investigating 
the calibration methodology and comparing the overall precision in the dosimetric 
data resulting from both dosemeters placed simultaneously on patients.  
 Most commercially available semiconductor detectors are designed to 
measure the dose at a certain depth in tissue as entrance dose measurements 
(Heukelom et al., 1991). A build-up cap usually covered these semiconductor 
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detectors to take the active measurement point to a depth of 0.5 to 2.0 cm (Rikner et 
al., 1987; Nilsson et al., 1988). 
 Direct entrance dose measurement method in patients during dose delivery is 
still one of the best methods in use in terms of reliability. Radiotherapy departments 
can detect discrepancies on incidence dose and finally the target dose. In vivo 
monitoring thus forms a part of quality assurance programs to optimize treatment 
strategy. However the financial burden and the complexity of in vivo procedures as 
well as the perturbation effects of the dosimeters in the irradiated fields are the major 
obstacles toward implementing full-strength entrance dose measurement programs. A 
new, simplified, convenient, and reliable technique is needed to be developed. There 
exists now a technique using LiF TLDs without buildup cap (Banjade et al., 2003) to 
measure the entrance dose in a patient undergoing radiotherapy which might prove to 
be beneficial. 
 
2.4 Contralateral Breast Dose during Breast Treatment 
Many studies have been done in regard to contralateral breast cancer (CBC). 
The researchers concentrate their studies into two main areas, the risk of contralateral 
breast (CB) and how to reduce the dose to the non-affected area. 
 
2.4.1 Contralateral Breast at Risk 
Regarding who is at risk, the only factor that has shown a link to increased 
CBC to radiotherapy is age and family history. Boice et al. (1992) examined the 
effect that the patient’s age has in the risk of developing second malignancies after 
radiation therapy treatment. The study concluded the relative overall increase in risk 
of CBC after the treatment for the primary target by radiation was 1.19. It was also 
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found that the relative risk was 1.59 for patients under the age of 45 at the time of the 
treatment and this increased to 1.85 for 10 year survivors who were under the age of 
45 at the time of the treatment. 
The risk factors of CBC have been reasonably consistent in incriminating 
family history and age at diagnosis of the first breast cancer (Bernstein et al., 1992; 
Chen et al., 1999; Harvey and Brinton, 1985; Hemminki and Vaittinen, 1999; Prior 
and Waterhouse, 1978). Because early age of onset is a strong risk factor, the relative 
risk of CBC compared to unilateral disease decreases with age (Gajalakshimi et al., 
1998; Harvey and Brinton, 1985; Prior and Waterhouse, 1978). The time interval 
between the first and the second breast cancer has been considered in some earlier 
studies and the risk has been highest in the first year of follow-up (Horn et al., 1987; 
Prior and Waterhouse, 1978). The data reported by Vaittinen et al., (2000) was 
agreed but the magnitude of effect was relatively small, with a relative risk of 1.28. 
The data on the effects of reproductive factors have been contradictory. The well-
established risk factors of unilateral breast cancer, late age at first childbirth and low 
parity, are not established risk factors of contralateral breast cancer: some studies 
exhibit effects, others exhibit no effects or exhibit even opposite effects, as reviewed 
by (Chen et al., 1999). Vaittinen et al., (2000) reported an exhibited a modest effect 
of parity and age at first childbirth.  
Gao et al. (2003) showed a relative risk of 1.32 for patients under 45 as well 
as a risk of 1.15 for patients over 55. These studies all suggest that the younger the 
patient was at the time of the radiation treatment, then the greater the risk that they 
may develop a secondary malignancy in CB. However, Obedian et al. (2000) found 
15 year follow up rates for patients under 45 of 10% for conservative surgery 
followed by radiotherapy and 7% for patients undergoing radical mastectomy. It was 
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concluded in the study that the increase was not statistically significant. Although the 
direct correlation between second malignancies and radiotherapy is not fully known 
and still under debate, it is a prudent practice to minimize any factor that may cause 
an increase in risk. 
 
2.4.2 Minimizing Contralateral Breast Dose 
 
Fraass et al. (1985) demonstrated, through various techniques, different 
methods to reduce the radiation peripheral dose during treatment. One of these 
techniques dealt with removing the wedge from medial tangential field. Other studies 
also show that the majority of the CB dose is produced by the medial tangent beam, 
whereas, the dose from the lateral tangent beam has to transverse through several 
centimeters of tissue before it reaches the CB. 
Tercilla et al. (1989) studied CB dose using half beam blocks and isocentric 
treatment techniques for 15 patients treated with primary breast radiotherapy using a 
Co-60 unit. They observed that the isocentric treatment technique is a simple solution 
for reduction of CB dose. On the other hand, Kelley et al. (1996) reported a study of 
four different techniques with a 6 MV linac beam. Using the Rando phantom and 
TLDs, they set up the beam arrangements as half beam with custom blocks, half 
beam using asymmetric collimator jaws, half beam using asymmetric collimator jaws 
with custom blocks, and isocentric technique with non divergent posterior border. 
They observed the highest dose for the medial field with a wedge and the lowest with 
asymmetric jaws and no medial wedge or block. 
Weides et al. (1995) and Warlick et al. (1997) evaluated the CB dose during 
breast irradiation using dynamic and regular wedges, with the development of the 
dynamic wedge and its application in breast conservation treatments, the absorbed 
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dose to the CB is reduced on average by 40%. These doses are only slightly higher 
than treatment with an open field. 
Bhatnagar et al. (2004) reported comparison of IMRT and conventional 
tangential field technique with wedges. They observed the CB dose of 7.24 ± 2.35% 
of the primary breast dose (5000 cGy) in IMRT and 9.24 ± 2.04% of the primary 
dose using the conventional tangential field technique. This shows a 20% reduction 
on dose to the CB dose (362 cGy IMRT and 462 cGy conventional). 
Muller-Runkel et al. (1990), Sohn et al. (1999), and Goffman et al. (2004) 
utilized in various methods lead shielding to reduce the dose to the CB. All showed a 
reduced dose in their studies. These reductions ranged from one third to one half of 
the original measured dose to the CB. Chougule et al. (2007) used a Co-60 unit to 
measure the dose to the CB for numerous patients. It was concluded that the dose 
generated by the medial tangential field was almost twice as much as the lateral 
tangential field. It was also postulated that a considerable amount of the dose from 
the lateral field was due to internal scatter and the dose from the medial field was 
primarily attributed to the scatter from the collimator. 
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CHAPTER 3 
GENERAL INSTRUMENTATION 
 
 
3.1 Introduction 
Proper and precise delivery of radiation consists of a complex series of 
events. These events must be controlled and monitored to ensure that the prescribed 
dose is given as accurately as possible in order for the treatment to be successful. The 
first control is established before the patient is even treated. It also involves the 
radiation delivery unit, the linear accelerator (linac). It must undergo extensive 
quality assurance tests. These tests keep the linac functioning within precise 
parameters that have been set up. 
The treatment of a cancer patient begins from a visit to the radiation 
oncologist. After a series of tests, the images (Simulator, CT, MRI, etc.) are captured 
for the purpose of diagnosis. The oncologist determines the stage of progress of the 
cancer and a treatment plan; chemotherapy, surgery, radiation, or any combination 
that may be administered. When radiation is the method chosen, the doctor gives a 
prescribed dose to treat the patient. This treatment may be a means to a cure or 
palliative. 
Once the method of treatment and dose are prescribed, the images from the 
patient’s CT scan are used to determine the contours of the critical organs and the 
cancerous growth(s). This is done using the treatment planning system (TPS) that 
corresponds to each individual linac. The limiting factor for the delivery of radiation 
is the consideration of the normal tissue surrounding the diseased area. Normal tissue 
can only be exposed to so much radiation dose before it cannot function properly. 
